Lisa H. Butterfield, Ph.D.
Lisa H. Butterfield, Ph.D., is the Vice President of the Parker Institute for Cancer Immunotherapy Research Center, and an Adjunct Professor of Microbiology and Immunology at the University of California, San Francisco. Her research is focused on the development of cancer vaccines and advanced cellular therapies. Dr. Butterfield was most recently Professor of Medicine, Surgery, Immunology and Clinical and Translational Science at the University of Pittsburgh (2003-2018) and Director of the Hillman Cancer Center Immunologic Monitoring and Cellular Products Laboratory. She holds a PhD in Biology from UCLA, followed by postdoctoral fellowships in Cellular Immunology and Cancer Gene Therapy also at UCLA. She was the President of SITC, 2017-2018 and a member of the SITC Executive Committee (2015-2020). She led the Immunology Reference Lab for the ECOG-ACRIN NCI cooperative group (2006-2018). She investigates immunotherapy for hepatocellular cancer and melanoma, involving peptides, dendritic cells and adeno viruses, and effector responses to tumor antigens. Dr. Butterfield has published over 150 peer-reviewed manuscripts, reviews and book chapters.